Company intelligence / Profile preview
Tatara Therapeutics
Redwood City, California, United Statestatararx.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Tatara Therapeutics has developed a proprietary iron-dependent drug conjugate technology to selectively target and kill cancer cells exhibiting altered iron metabolism. The company’s approach leverages metabolic vulnerabilities in tumor cells—particularly those with mutant RAS—by activating drugs only within the high-ferrous environment of these cancers. As of early/mid–2024, all programs are preclinical; no clinical results have been reported yet.[1][2][3]
- Therapeutic areas
- Oncology
- Modalities
- Iron-activated drug conjugates (FeADC™)Small molecules (inferred from platform description)Potentially antibody-drug conjugates or similar, based on "drug conjugate" terminology[3]
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Described as having partnerships with five biotech/pharma companies as of January 2023; specific partners not named.[5] No major licensing deals publicly disclosed.
Beyond the preview
Go deeper on Tatara Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tatara Therapeutics.